The press release from NICE says that: Quality standards are a set of specific, concise statements and associated measures [that] set out aspirational, but achievable, markers of high-quality, cost-effective patient care, covering the treatment and prevention of different diseases and conditions. NICE have already published quality standards on dementia and depression in adults and they have [read the full story…]
There is evidence from epidemiological studies that low levels of zinc are associated with depression, but good quality clinical trials that explore the link between zinc supplementation and depression are few and far between. This systematic review conducted by a research team from the University of Newcastle in New South Wales, Australia, aimed to synthesise results from [read the full story…]
It has been widely reported that antipsychotics have been frequently used to treat the behavioural and psychological symptoms that affect people with dementia and that this course of action has resulted in an estimated 1,800 excess strokes and 1,600 excess deaths in the UK alone. This double-blind, parallel-group, placebo-controlled randomised trial looks at one of the [read the full story…]
The Department of Health have published an updated guide summarising the health harms of drug and alcohol misuse, which is aimed at supporting non-medical practitioners working with substance misuse issues. The document updates the 2003 “Dangerousness of Drugs” guide. It’s an 80-page PDF report and it outlines acute and chronic problems associated with each substance, [read the full story…]
There are a number of cross-sectional studies that investigate antidepressant use in teenagers and young adults. These are interesting, but because they don’t tend to follow-up study participants prospectively over a long period of time, there is only so much we can learn from them. However, now researchers in Finland have published a study that [read the full story…]
The PEARLS Program is a team-based approach, involving counsellors, psychiatrists and medical providers, designed to reduce depressive symptoms and improve quality of life in adults with epilepsy. It was developed by a team at the University of Washington and has been studied through two randomised controlled trials, the second of which measures the long-term benefits of [read the full story…]
Some of the risk factors for suicide are well known. Research shows that mental illness is the most significant risk factor and we also know that gender plays a big part (men are at greater risk). However, some of the other potential risk factors are less well study, such as the impact that serious physical [read the full story…]
Researchers from Oxford and Verona have published a major new meta-analysis in the Lancet, which measures the effectiveness of all anti-manic drugs. The review team searched and found 68 randomised controlled trials from 1980-2010 (a total of 16,073 patients). The study includes a range of antipsychotics and mood stabilisers used at a therapeutic dose range [read the full story…]
We know very little about how to increase the safety and wellbeing of mothers who experience intimate partner violence. A good deal of the research in this field focuses on treatments delivered by health professionals, but this cluster randomised trial from Melbourne Australia looked at the impact that non-professional mentor support can have in reducing [read the full story…]
There are a number of epidemiological studies that suggest a clear relationship between levels of vitamin D in the body and mental well being, but to date there has not been a large scale randomised controlled trial that proves that vitamin D supplementation (serum 25-hydroxyvitamin D levels) can improve mental health. An Australian research team [read the full story…]
